Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Pharma 5.0
Company News
Events
Directory
Search
Close search
Home
Jubilant Life Sciences
Jubilant Life Sciences
Activities:
Manufacturing
Ingredients
Pharmaceutical
X
LinkedIn
Trending Articles
Counteracting counterfeits in the pharmaceutical supply chain
Sreedhar Patnala, General Manager at Systech, discusses the comprehensive benefits of embracing traceability
How AI can optimise your pharmaceutical manufacturing processes and raise throughput
Artificial intelligence (AI) allows pharmaceutical manufacturers to perform predictive maintenance, which can reduce downtime and enhance process efficiency
Merck attains $588m global license for PD-1/VEGF bispecific antibody from LaNova Medicines
The bispecific antibody is designed for oncological indications and functions by inhibiting the PD-1/PD-L1 and the VEGF/VEGFR receptor signalling pathways
Bormioli Pharma to digitise package leaflets using augmented reality
The project is part of the Bormioli Pharma Invents innovation programme, which aims to provide concrete answers to some of the most important challenges in the pharmaceutical...
Syncona launches early-stage drug development company, Slingshot Therapeutics
The novel early-stage pharmaceutical company aims to collaborate with academic institutions to bring their findings to the clinic, with their first programme centring around...
Upcoming event
CPhI India
26–28 November 2024 | Online Conference & Networking | Delhi, India
See all
Related Content
Distribution
Biesterfeld and Jubilant celebrate 25 year partnership on fine chemicals
Biesterfeld Spezialchemie distributes Jubilant Ingrevia’s selected range of products in the field of advanced intermediates to selected customers across Europe
Manufacturing
ON-DEMAND WEBINAR: Delivering the added dimension in Scale-up
Watch Jubilant Biosys' complimentary webinar and live Q&A, hosted in association with Manufacturing Chemist on 7 July, 2020
Delivering the added dimension in Scale-up
7 July 2020 | Webinar
Manufacturing
Jubilant Biosys begins two drug discovery facility expansions in India
The CRO has invested in expansion of the Greater Noida and Bengalaru facilities
Research & Development
Jubilant Biosys strengthens its leadership team with two key appointments
Hires Steven Hutchins as President and Dr Takeshi Yuri as VP of Medicinal Chemistry
Manufacturing
Jubilant Life Sciences to sell licensed and proprietary diabetes and cardiovascular products
Has seen substantial growth in its domestic Indian market with such products
Finance
IFC makes major loan to Jubilant Pharma
To boost generics production
Subscribe now